*001884300
*00520230331161106.0
*007cr
*007ta
*008120424s1995    no#           000 0 eng
*00901851cam a2200505 c 4500
*015  $a9607937$2nbf
*019  $bl
*020  $a8299381207$qh.
*035  $a(EXLNZ-47BIBSYS_NETWORK)999602402334702201
*035  $a(NO-LaBS)14210558(bibid)
*035  $a(NO-TrBIB)092107095
*035  $a(NO-TrBIB)960240233
*035  $a960240233-47bibsys_network
*040  $aNO-OsNB$bnob$ekatreg
*042  $anorbibl
*044  $cno
*060 4$aQV 269
*060 4$aQZ 267
*080  $a616-006.6
*08274$a616.994$qNO-OsNB$24/nor
*084  $a24.0$qNoOU$2no-ureal-cb
*084  $aFh:600$2utk
*1001 $aDunsæd, Camilla Bruno$_113909600
*24510$aAntitumour activity and pharmacokinetics of a deuterated benzaldehyde derivative 4,6-benzylidene-d?-D-glucose (P-1013)$cby Camilla Bruno Dunsæd
*260  $aOslo$bC. Dunsæd$c1995
*300  $a1 b. (flere pag.)$bill.$c30 cm
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling (dr. scient.) - Universitet i Oslo, 1996
*533  $aElektronisk reproduksjon$b[Norge]$cNasjonalbiblioteket Digital$d2008-02-20
*650 2$aAntineoplastic Agents$_10522400
*650 2$aBenzaldehydes$xtherapeutic use$_113909700
*650 2$aBenzylidene Compounds$xpharmacokinetics$_113909800
*650 2$aDissertations, academic$_10492300
*650 2$aNeoplasms$xDrug therapy$_15542500
*650 7$aBiokjemi$0(NO-TrBIB)REAL003065$2noubomn$_185508700
*650 7$aCellegift$0(NO-TrBIB)REAL012455$2noubomn$_219964600
*650 7$aFarmakokinetikk$0(NO-TrBIB)REAL005365$2noubomn$_185712700
*650 7$aKreft$0(NO-TrBIB)REAL009987$2noubomn$_185515100
*653  $adoktoravhandlinger$abiokjemi$afarmakokinetikk$akreft$akreftbekjempelse$aanti-tumor$acellegift$_113909900
*85641$3Fulltekst$uhttps://urn.nb.no/URN:NBN:no-nb_digibok_2008022004096$yNettbiblioteket$zDigital representasjon
*901  $a90
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:999602402334702202$b2021-11-14T20:56:33Z$z999602402334702202
^